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Background
cAMP-dependent protein kinase (PKA) and cGMP-
dependent protein kinase (PKG) are the main effectors of
distinct cyclic nucleotide pathways and are preferentially
activated by cAMP or cGMP, respectively.
We recently characterized the isolated C-terminal cyc-
lic nucleotide binding domain (CNB-B) of the human
PKG Ib as highly cGMP-selective (manuscript in pre-
paration). In a crystal structure of the CNB-B two novel
cGMP-specific interaction sites were identified in addi-
tion to the previously described threonine residue (T317)
in the phosphate binding cassette [1]. Mutation of each
individual site resulted in reduced cGMP-selectivity and
interfered with cGMP-dependent activation of PKG Ib.
To gain further insight into the molecular basis of cyc-
lic nucleotide selectivity, we inserted two cGMP-specific
interaction sites into the CNB-B of human PKA RIa by
mutating corresponding residues. We hypothesize that
this way cGMP-specific interaction contacts can be cre-
ated in PKA and thereby modulate cAMP-selectivity
[1,2].
Results
We characterized a deletion construct of the PKA hRIa
CNB-B as cAMP-selective using fluorescence polarization
(FP) and surface plasmon resonance (SPR).
In comparison to the wildtype PKA hRIa CNB-B, single
mutant constructs showed similar affinities for cAMP-
and cGMP-analogs, revealing a loss of selectivity. The
combination of two mutations led to a construct with
higher affinity for cGMP compared to cAMP.
Co-crystal structures of this double mutant with cAMP
or cGMP, respectively, showed that the cGMP-specific
interaction contacts retained their function in the context
of the PKA hRIa CNB-B.
Conclusion
The general structure of cyclic nucleotide binding
domains is conserved. However, varying amino acids in
the binding pocket enable the distinction between cAMP
and cGMP. Here we show that cGMP interaction sites
found in PKG do restore their specific binding mechan-
isms when introduced into PKA.
The results underline the relevance of the described
novel binding sites in mediating cGMP-selectivity. Still,
other features of CNB domains involved in the specific
binding mechanism as well as the detailed mechanism of
kinase activation need to be investigated.
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